Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |